Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM, van den Akker ELT, Verwaaijen EJ, Fiocco M, Rensen N, van Litsenburg RRL, Pluijm SMF, Zwaan CM, van Santen HM, Pieters R, Evers AWM, Grootenhuis MA, van den Heuvel-Eibrink MM. van Hulst AM, et al. Eur J Cancer. 2023 Jul;187:124-133. doi: 10.1016/j.ejca.2023.03.039. Epub 2023 Apr 7. Eur J Cancer. 2023. PMID: 37149961 Free article. Clinical Trial.
The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemia.
Verwaaijen EJ, van Hulst AM, Molinger J, Hartman A, Pieters R, Grootenhuis MA, van den Akker ELT, van den Heuvel-Eibrink MM. Verwaaijen EJ, et al. Among authors: van hulst am. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2216-2225. doi: 10.1002/jcsm.13305. Epub 2023 Aug 10. J Cachexia Sarcopenia Muscle. 2023. PMID: 37562959 Free PMC article.
Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM, Grootenhuis MA, van den Akker ELT, van den Heuvel-Eibrink MM. van Hulst AM, et al. Eur J Cancer. 2023 Sep;191:112980. doi: 10.1016/j.ejca.2023.112980. Epub 2023 Aug 11. Eur J Cancer. 2023. PMID: 37574396 Clinical Trial. No abstract available.
Physical frailty deteriorates after a 5-day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study.
Verwaaijen EJ, van Hulst AM, Hartman A, Pieters R, Fiocco M, Pluijm SMF, van Litsenburg RRL, Grootenhuis MA, van den Akker ELT, van den Heuvel-Eibrink MM. Verwaaijen EJ, et al. Among authors: van hulst am. Cancer Med. 2023 Dec;12(24):22304-22315. doi: 10.1002/cam4.6779. Epub 2023 Dec 9. Cancer Med. 2023. PMID: 38069550 Free PMC article.
Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.
van Hulst AM, Verwaaijen EJ, Fiocco MF, Pluijm SMF, Grootenhuis MA, Pieters R, van den Akker ELT, van den Heuvel-Eibrink MM. van Hulst AM, et al. BMC Pediatr. 2021 Sep 27;21(1):427. doi: 10.1186/s12887-021-02896-6. BMC Pediatr. 2021. PMID: 34579671 Free PMC article.
A Comatose Patient with a Bluish Tongue.
van Hulst AM, Lammers HJW, Koekkoek WACK, Smulders CA, Tjan DHT. van Hulst AM, et al. Clin Chem. 2018 Aug;64(8):1143-1145. doi: 10.1373/clinchem.2017.278200. Clin Chem. 2018. PMID: 30054299 No abstract available.
18 results